BioLife Solutions (BLFS)
NASDAQ:BLFS
Want to see BLFS full AI Analyst Report?
Total Valuation
BioLife Solutions has a market cap or net worth of $1.27B. The enterprise value is $1.24B.
Market Cap$1.27B
Enterprise Value$1.24B
Share Statistics
BioLife Solutions has 48,857,414 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,857,414
Owned by Insiders16.21%
Owned by Institutions10.65%
Financial Efficiency
BioLife Solutions’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -0.28%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-0.28%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee605.12K
Profits Per Employee-28.90K
Employee Count159
Asset Turnover0.24
Inventory Turnover1.13
Valuation Ratios
The current PE Ratio of BioLife Solutions is ―. BioLife Solutions’s PEG ratio is 2.24.
PE Ratio―
PS Ratio12.00
PB Ratio3.10
Price to Fair Value3.10
Price to FCF108.55
Price to Operating Cash Flow70.51
PEG Ratio2.24
Income Statement
In the last 12 months, BioLife Solutions had revenue of 96.21M and earned -12.13M in profits. Earnings per share was -0.25.
Revenue96.21M
Gross Profit62.12M
Operating Income-1.08M
Pretax Income-12.08M
Net Income-12.13M
EBITDA3.61M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was 17.90M and capital expenditures -19.69M, giving a free cash flow of -1.79M billion.
Operating Cash Flow17.90M
Free Cash Flow-1.79M
Free Cash Flow per Share-0.04
Dividends & Yields
BioLife Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.41
52-Week Price Change21.91%
50-Day Moving Average23.28
200-Day Moving Average23.98
Relative Strength Index (RSI)55.80
Average Volume (3m)363.00K
Important Dates
BioLife Solutions upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
BioLife Solutions as a current ratio of 5.94, with Debt / Equity ratio of 3.99%
Current Ratio5.94
Quick Ratio4.63
Debt to Market Cap<0.01
Net Debt to EBITDA-4.20
Interest Coverage Ratio-0.40
Taxes
In the past 12 months, BioLife Solutions has paid 49.00K in taxes.
Income Tax49.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioLife Solutions EV to EBITDA ratio is 316.01, with an EV/FCF ratio of 107.13.
EV to Sales11.84
EV to EBITDA316.01
EV to Free Cash Flow107.13
EV to Operating Cash Flow56.65
Balance Sheet
BioLife Solutions has $81.00M in cash and marketable securities with $14.86M in debt, giving a net cash position of $66.14M billion.
Cash & Marketable Securities$81.00M
Total Debt$14.86M
Net Cash$66.14M
Net Cash Per Share$1.35
Tangible Book Value Per Share$3.33
Margins
Gross margin is 63.89%, with operating margin of -1.12%, and net profit margin of -12.61%.
Gross Margin63.89%
Operating Margin-1.12%
Pretax Margin-12.56%
Net Profit Margin-12.61%
EBITDA Margin3.75%
EBIT Margin-1.12%
Analyst Forecast
The average price target for BioLife Solutions is $33.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$33.20
Price Target Upside65.09% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast-5.48%
EPS Growth Forecast-666.94%